Front-line clinical pharmacy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Front-line clinical pharmacy

Background There is strong evidence supporting that pharmacist involvement strengthens the quality of the medication process. There is also evidence indicating that many emergency admissions among the elderly are medicine related. Based on this existing knowledge, it was decided to investigate whether implementation of clinical pharmacy in the Emergency Department could make a further difference.

متن کامل

Front-line Facilitators

Despite a great deal of academic debate surrounding the term ‘restorative justice’, it would appear fair to suggest that the majority of the research in this area focuses upon the three main stakeholders involved within the process, namely the victim, the offender and the community, victim-offender mediation, and the benefits of such an approach. Nonetheless, not only can this can be seen to ne...

متن کامل

On the front line.

14 The drylands are on the front line of climate change, and they include the world’s poorest and most vulnerable people. We are already seeing in them the harrowing effects of climate change on poverty, survival, health, hunger, human well-being — and on peace itself, because the heavily impacted drylands are among the most unstable parts of the world. The stretch from Senegal through to Afgha...

متن کامل

Social Pharmacy and Clinical Pharmacy—Joining Forces

This commentary seeks to define the areas of social pharmacy and clinical pharmacy to uncover what they have in common and what still sets them apart. Common threats and challenges of the two areas are reviewed in order to understand the forces in play. Forces that still keep clinical and social pharmacy apart are university structures, research traditions, and the management of pharmacy servic...

متن کامل

Clinical pharmacy and clinical trials

CPC-148 Table 1 adalimumab infliximab ustekinumab Lost to follow-up 5% (1/20) 23.5% (4/17) 22% (2/9) Continuing treatment 40% (8/20) 29.4% (5/17) 67% (6/9) Withdrawal/ Discontinuation by doctor 5% (1/20) 5.9% (1/17) 11% (1/9) Discontinuation due to good response 20% (4/20) – – Change of treatment 30% (6/20) 41.2% (7/17) – The causes of the discontinuation/change of treatment were: Abstract CPC-...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

سال: 2012

ISSN: 1757-7241

DOI: 10.1186/1757-7241-19-s2-p24